SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Market Cap
IN₹4.22tn
Enterprise Value
IN₹3.93tn
Revenue
IN₹584.62bn

All News

India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures

Sun Pharmaceutical Industries

07/10/2026 16:16

India's Sun Pharmaceuticals to consider raising $1.55 billion via debenturesOct 7 (Reuters) - India's Sun Pharmaceuticals SUN.NS on Wednesday said it would consider raising up to 150 billion rupees ($1.55 billion) via non-convertible debentures at its board meeting on October 12. 
     
($1 = 96.6682 Indian rupees)

(Reporting by Abhirami G in Bengaluru; Editing by Jonathan Ananda)
((abhirami.g@thomsonreuters.com))

SUNPHARMA — Sun Pharmaceutical Industries News Story

India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures

Recent news on Sun Pharmaceutical Industries

Brief: Sun Pharma Says Unloxcyt Receives Category 2A Designation In NCCN Guidelines For LACSCC

India New Issue-Sun Pharma to issue over five-year bonds, bankers say

India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say

Brief: Sun Pharma Approves Issuance Of NCDs Worth Up To 100 Billion Rupees

Brief: Sun Pharma To Consider Issuance Of NCDs Up To 150 Billion Rupees